Medium impact
January 2025 Medicaid Information Bulletin
Utah Medicaid·Effective Jan 1, 2025
HCPCS C9169 is officially defined as "Injection, nogapendekin alfa inbakicept-pmln, for intravesical use, 1 microgram." HCPCS C9169 is referenced in 1 tracked payer policy change from Utah Medicaid. For billers and coders, staying current on payer-specific coverage criteria, reimbursement rules, and prior-authorization requirements for HCPCS C9169 is critical to clean claim submission. Each entry below links to the full policy analysis with effective dates and action steps.
Related
Get alerts for changes like this
Save a search and receive a daily digest whenever a new policy change matches your filters.